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Background {#Sec2}
----------

As we enter the second decade of the 21^st^ century, experts agree that the world faces three major global health challenges. The first is completing the work to meet the millennium development targets of decreased malnutrition and infectious disease. The second is the alarming increase in the incidence of chronic diseases like heart disease, Type II diabetes, obesity, and cancers in developing nations. The third is a consequence of globalisation whereby traditional diets are being replaced or supplemented with nutritionally compromised fast-foods. Nutrition is a feature of each of these challenges, and in a sad twist of irony, developing countries, where rice is the staple, are the hardest hit by all three of these global challenges.

Over the past decade, rice improvement programs have included key nutritional targets in their breeding programs, attempting to meet specific targets for Fe, Zn and pro-vitamin A content. During this time, significant progress has been made in understanding both ways to increase the micronutrient content of the polished and unpolished rice, and the limitations to achieving those targets in conventional breeding programs. However, the potential of rice to contribute to the prevention or management of chronic diseases is not so widely recognised, and research aimed to quantify that potential receives a fraction of the public funding of rice and malnutrition, despite the massive and growing problem of chronic disease that prevails in all rice-consuming countries (\[[@CR116]\]). Perhaps this is because the association between compounds in rice grains and chronic diseases is more complex and less intuitive than, for example, increasing Zn content of grains to address Zn deficiency. A second reason could be limitations in the detection and identification of relevant grain constituents, meaning that phenotyping tools are not available for breeding objectives. The previous decade has borne witness to breath-taking technological advances, which should enable research to progress more rapidly both in identifying grain constituents, and determining the impact of these in the prevention or management of chronic diseases.

This review will focus on the nutritional potential of grains of both polished and unpolished rice, for the most pressing issues of malnutrition and chronic diseases in rice-consuming countries. We discuss opportunities and obstacles, and identify roles that rice might play in health and nutritional impact, and patterns of rice consumption that could contribute to solutions for the grand challenges to global health.

Malnutrition {#Sec3}
============

Malnutrition in rice-consuming populations {#Sec4}
------------------------------------------

Iron deficiency anaemia is a worldwide public health problem, with global prevalence estimated at 24.8% (95% CI: 22.9--26.7) (\[[@CR151]\]). It occurs when the concentration of haemoglobin (Hb) falls below 11 g/dl in pregnant women, 12 g/dl in non-pregnant women aged 15--49, and 11 g/dl in children under five. Anaemia can cause maternal mortality associated with childbirth. In adults it lowers work performance, and it has been linked with reduced immune competence (\[[@CR151]\]). The majority of the disease burden is shouldered by developing countries with high levels of rice consumption. The highest prevalence is found in Africa, the Middle East, Central, South and South-East Asia, and areas of Latin America, where two thirds of children under five, and almost 50% of women are anaemic (\[[@CR186]\]). One reason that Fe-deficient anaemia is widespread amongst rice-consuming countries is because of the low concentration of Fe in polished rice, like other starchy staples, combined with the inability of poor people to supplement the staple with other foods rich in micronutrients. A survey of 56 varieties showed that the average Fe content of the polished grains was 4.3 ppm (\[[@CR22]\]); however, the biological availability of Fe from polished rice is low (\[[@CR151]\]).

The first cases of zinc deficiency were described in the Middle East the 1960s, and attributed to the consumption of diets high in anti-nutritional factors (\[[@CR131]\]). Zn deficiency is now recognised as one of the five major factors contributing to disease burden in developing countries (\[[@CR185]\]). Zn deficiency leads to decreased neuropsychological function, it contributes to childhood mortality by increasing the incidence and severity of acute and chronic diarrhoea, and in pregnant women it leads to difficulties in childbirth, retarded foetal growth, and foetal abnormalities (\[[@CR130]\];\[[@CR163]\]). The prevalence of Zn deficiency in developing countries is similar to that of Fe deficiency, since the same dietary pattern, a reliance on polished rice with minimal dietary diversity, contributes to both (\[[@CR18]\]). In Central, South and South-East Asia and sub-Saharan Africa, stunting due to Zn deficiency affects 40% of preschool children (\[[@CR75]\]), and 82% of pregnant women (\[[@CR16]\]). Most Latin Americans living in poverty consume a diet rich in cereals and beans, and low in animal products (\[[@CR128]\]), and therefore record high levels of Zn deficiency (\[[@CR6]\];\[[@CR186]\]).

Vitamin A deficiency (VAD) is as a public health problem among preschool-aged children in 118 developing countries around the globe (\[[@CR183]\]). Vitamin A deficiency occurs when serum retinol is less than 0.7 μmol/l, or less than 20 μg/dl in children below 6 years. The prevalence of VAD among school-aged children (5-15y) in Latin American, South and Southeast Asian countries varies from 6% in Sri Lanka to 36% in El Salvador (\[[@CR6]\];\[[@CR183]\]).

Vitamin A plays a major role in phototransduction, and deficiency leads to xerophthalmia followed by complete blindness (\[[@CR103]\]). Beta-carotene is the precursor of Vitamin A. In a survey of 3000 varieties of rice, only 20 varieties were found to contain β-carotene (\[[@CR44]\]). The amount of β-carotene detected in those 20 was less than 0.2 ppm, and it was found only in the bran layer; no β-carotene was detected in the polished grains of any of the varieties (\[[@CR44]\]). Therefore people deriving most of their calories from polished rice are at the highest risk of VAD, since other staples, such as certain varieties of wheat, maize and orange-fleshed sweet potatoes contain β-carotene.

Solutions to malnutrition through rice {#Sec5}
--------------------------------------

In the context of such widespread malnutrition in the world's major rice consuming countries, agricultural strategists recognised a potential role for rice, if breeding programs could elevate the micronutrient levels in rice (\[[@CR21]\]). This led to a paradigm shift in breeding programs, as selection for nutritional traits commenced, with the objectives of elevating Fe and Zn, and incorporating β-carotene into polished grains. This program was first launched under the umbrella of the Consultative Group for International Agricultural Research (CGIAR) Micronutrient Program, which then underwent reform in 2004 to become Harvestplus, an autonomous organisation that sets the targets and coordinates the multilateral efforts to increase Fe, Zn and β-carotene in staple crops, including rice (<http://www.harvestplus.org>).

The minerals in unpolished rice of 60 popular varieties (Table[1](#Tab1){ref-type="table"}) show that there is less than 10% variability for all minerals except Zn, Mn, and Cu. By exploring wider sources of diversity within the species, significantly more variability was found for the amount of Fe and Zn in unpolished rice (\[[@CR56]\]). However it is not always possible to extrapolate data from unpolished rice to white, polished rice. By replotting data of 70 varieties of unpolished rice and the same varieties polished to a degree of milling of 10% (\[[@CR22]\]), it can be seen that the Fe content of all the polished rices clusters around 4 -- 5 ppm, despite variation in Fe before removal of the bran layer (Figure[1](#Fig1){ref-type="fig"}). By contrast, the Zn content of the unpolished grains shows an association with the Zn content when the grains are polished, and also shows a range in Zn contents of polished rice from 10 -- 20 ppm (Figure[1](#Fig1){ref-type="fig"}). Table 1**Amount of selected micro and macro minerals in unpolished grains of 60 popular rices from South-East Asia (Data from Indrasari 2002)**CaPMgKSFeZnMnCu**Amount (ppm)**92.443720.591488.822823.531309.1211.6923.8932.513.07**Standard deviation**14.13243.43103.59264.07111.371.713.967.251.04Figure 1**Fe (squares) and Zn (circles) content of unpolished and polished rice of seventy varieties of rice.**

In the past ten years, significant international effort has been expended to search the diversity of the species for elevated Fe and Zn in the polished grain (\[[@CR78]\];\[[@CR82]\];\[[@CR93]\];\[[@CR94]\];\[[@CR96]\];\[[@CR101]\];\[[@CR170]\];\[[@CR175]\];\[[@CR180]\];\[[@CR182]\]). As suggested by Figure[1](#Fig1){ref-type="fig"}, variation for Zn content was discovered, and focussed selection and careful phenotyping has enabled rice improvement programs to release varieties with elevated Zn (\[[@CR179]\]). Models using the levels of Zn that can now be achieved in polished rice suggest that the increase in Zn will lead to a significant decrease in the prevalence of Zn deficiency in both adults and children in rural Bangladesh (\[[@CR9]\]).

After searching widely through the diversity of the species, and its wild relatives, rice improvement programs have not found variation in the endosperm for Fe. This suggests that there is either physiological regulation of the Fe that exchanges from the maternal to the filial tissues; or no biological reason, therefore mechanism, for Fe to accumulate in the endosperm. Rice improvement programs have therefore concluded that elevating Fe in the grain can only be achieved by the use of transgenic techniques (\[[@CR83]\]).

Transgenic technology successfully elevates Fe in the grain, suggesting no physiological barrier regulating it. In one study, a ferritin gene from soybean was expressed in the endosperm, leading to the accumulation of Fe (\[[@CR132]\];\[[@CR175]\]). Another study pyramided a ferritin gene from common bean into the grain to increase Fe, with a phytase gene from *Aspergillus* to increase bioavailability of the Fe (\[[@CR100]\]). More recently, one study showed a significant increase in Fe content of polished grains by expressing a nicotianamine synthase (*NAS*) gene from barley in the rice endosperm (\[[@CR153]\]). In another study, the *NAS* genes from rice, *OsNAS1*, *OsNAS2* and *OsNAS3*, that usually express in roots and shoots, were expressed in the endosperm leading to levels of Fe in polished grains that meet and exceed the Harvestplus targets (\[[@CR83]\]). Taken together, these studies show that it is possible for iron to enter the endosperm in different forms, and the studies all indicate that a mechanism to import Fe into the endosperm has simply not previously evolved. The ability for different forms of Fe to accumulate provides options to maximise its bioavailability.

The small amount of iron that occurs naturally in the grain and the aleurone layers of the endosperm was unable to reverse Fe-induced anaemia in women (\[[@CR59]\]). Transgenic rice with the ferritin gene from soybean was able to reverse anaemia in rats with the same efficiency as FeSO~4~ (\[[@CR109]\]), but the same rice had no effect on iron status of piglets (\[[@CR145]\]). These contradictory findings suggest that bioavailability of ferritin is complex. By contrast, the Fe chelated in nicotianamine was found to be bioavailable to humans (\[[@CR199]\]). This suggests an argument for testing the most powerful gene for elevating endosperm Fe, *OsNAS2* (\[[@CR83]\]), in other genetic backgrounds, to test (i) if the phenotype is the same in different genetic backgrounds, (ii) for any negative effect on grain yield and grain quality, and (iii) whether the next generation of seedlings, nourished by the endosperm, suffers any effect due to the presence of the iron in the endosperm. Varieties expressing *OsNAS2* in the endosperm possibly offer a solution, other than by reason of bioavailability, to reversing Fe-anaemia. The other transgenic examples use genes from other species to accumulate Fe, whereas those with *OsNAS2* in the endosperm accumulate Fe using a gene that naturally occurs in rice. Transgenic technology was used only to change the expression pattern of that gene. This difference in the degree of transgenic technology, where transgenic techniques were only used to change where the gene expresses in the plant, could ease the road to deregulation and the grains might be acceptable to a wider group of consumers.

A solution to VAD is being tested using transgenic technology to insert the genes necessary to enable the rice grain to accumulate β-carotene, creating Golden Rice (\[[@CR15]\];\[[@CR58]\]). The transgenes have recently been crossed into popular and high-yielding varieties using conventional breeding techniques (<http://irri.org/news-events/hot-topics/golden-rice>). Recently, a preliminary feeding trial in the US showed that the β-carotene from Golden Rice is efficiently converted to retinol (\[[@CR164]\]). However, there is very little other information in the public arena about the effect of the transgenes on nutritional, sensory and postharvest quality of the grains of Golden Rice. The high bioavailability, relative to some other sources, was ascribed to the simple starch matrix of the rice (\[[@CR164]\]). In carrots, β-carotene is located in crystalline chromoplasts where it is less bioavailable than the β-carotene from mangoes, which is held in lipid droplets (\[[@CR23]\]). The location of β-carotene in rice grains is unknown, but its high bioavailability suggests that it is not in chromoplasts. This could also mean that the β-carotene is susceptible to auto-oxidation (\[[@CR135]\]). After harvest, rice is usually dried to about 12% moisture for storage. In a starch system containing crystalline β-carotene, and stored at room temperature for four weeks at 11% moisture, a 30% loss in β-carotene, due to auto-oxidation was found (\[[@CR135]\]). Presumably the creators of Golden Rice have achieved a balance between bioavailability and loss due to auto-oxidation, in order to maximize the potential impact on the consequences of VAD, and have fully characterized any oxidation products that could accumulate in grains. Wider performance testing, including yield trials as well as clinical trials with VAD-deficient target populations in developing countries will be conducted in the near future to verify both bioavailability and potential health benefits of Golden Rice (<http://irri.org/news-events/hot-topics/golden-rice>). Assuming that all regulatory requirements will be met, IRRI projects that Golden Rice may be ready for release in 2013 (<http://www.irri.org>).

Chronic diseases {#Sec6}
================

Chronic diseases in rice consuming countries {#Sec7}
--------------------------------------------

The total number of people with Type II diabetes mellitus (DM) is projected to rise from 171 million in 2000 to 366 million in 2030 (\[[@CR187]\]). Figure[2](#Fig2){ref-type="fig"} shows the prevalence of Type II DM in each country in 2010, and the projected distribution by 2030 (\[[@CR150]\]). Saudi Arabia and North America have the highest prevalence (Figure[2](#Fig2){ref-type="fig"}). By 2030, a significant increase in prevalence is seen for Latin America, Africa, and South and Southeast Asia (\[[@CR150]\]). One of the major risk factors is that developing countries are changing their eating habits (\[[@CR106]\]), leading to an obesity epidemic, termed the nutrition transition (\[[@CR10]\];\[[@CR74]\];\[[@CR194]\]). In many developing countries, low fat diets are being replaced by fast foods that are high in fat, and this is leading to significant increases in obesity (\[[@CR80]\]). The increase in the proportion of the population with obesity is one of the greatest risk factors for diabetes, coronary disease and some cancers (\[[@CR89]\]). Coupled with population growth, rice consuming countries are heading towards a major public health crisis, with significant financial risk at both the household and national levels. Figure 2**Global distribution of the prevalence of type II diabetes in 2010 (a) and project in 2030 (b).** Replotted from the Diabetes Atlas data ([www.idf.org/diabelesatlas](http://www.idf.org/diabelesatlas)).

Each year, an estimated 2.5 billion cases of diarrhoea occur among children under five years of age (\[[@CR197]\]). Significantly, the median incidence of diarrhoeal diseases in children under five in developing countries has changed little since the early 1990s (\[[@CR81]\];\[[@CR124]\]). More than half of these cases are in Africa and South-East Asia, where bouts of diarrhoea are more likely to result in death or other severe outcomes, such as significant loss of vitamins and minerals (\[[@CR172]\]). By placing these figures and trends in the context of the United Nations Millennium Development Goal 4, which aims to reduce childhood mortality by two-thirds between 1990 and 2015, it becomes clear that many countries in South-East Asia might not meet this target (\[[@CR195]\]). In addition, these data provide an illustration of the vicious cycle of malnutrition, where chronic diarrhoea could prevent children from reaping nutritional benefits of rice varieties, developed especially to address malnutrition, with elevated concentrations of vitamins and minerals.

In 2000, more than half the 16.7 million world deaths from cardiovascular diseases were in developing countries, (\[[@CR184]\]) many of these in South and South-East Asia. Coronary deaths in India are expected to double over the next 20 years (\[[@CR52]\]), and they reached 2 million in 2010. Cardiovascular diseases were the leading cause of death Malaysia (\[[@CR157]\]), which is mainly due to hypercholesterolaemia and hypertension (\[[@CR156]\];\[[@CR196]\]). In 1998, the cause of death from cardiovascular disease in Bangladesh was 12.5%, Bhutan 14.8%, India 13.0%, Indonesia 23.2%, Maldives 24.8%, Myanmar 12.7%, Nepal 1.9%, Sri Lanka 20.1%, and Thailand 17.1% (\[[@CR185]\]).

Cardiovascular disease is a far greater public health problem in developing countries than previously realized, particularly in younger people, according to a report that combined population estimates for five lower to middle income countries with current death rates and workforce data to calculate the effects of cardiovascular disease on society and on the workforce. A conservative estimate showed that at least 21 million years of future productive life were lost each year in the five countries because of cardiovascular disease. Future predictions were even more disturbing, with the number set to rise to 34 million years of life lost by 2020 (\[[@CR98]\]).

The cost of managing cardiovascular diseases has been increasing in several countries and regions of the world (\[[@CR92]\]). One study estimated the burden of cardiovascular diseases in 24 countries of the European Union, and reported the financial burden of cardiovascular diseases was €169 billion per year, with direct healthcare costs accounting for 62% of the cost, followed by costs of informal care, and indirect costs associated with loss of production due to early death, and the loss of productivity due to morbidities (\[[@CR92]\]).

Potential solutions to chronic diseases from rice {#Sec8}
-------------------------------------------------

Whole-grains are the unpolished version of cereal grains, consisting of the germ, bran, and endosperm; while polished grains lack both the germ and bran. The scientific community generally considers whole-grain foods to include those that contain the same amount of germ and bran that would typically be found in the unprocessed grain (\[[@CR147]\]). By this definition, whole-grain rice, whether consumed intact or pulverised into flour, is a whole-grain food. Consequently, epidemiological studies designed to identify dietary patterns associated with reduced incidence of chronic disease typically classify unpolished, or brown, rice as a whole-grain (\[[@CR79]\];\[[@CR181]\]). There is a significant corpus of research describing components in whole-grain rice which have potential for nutritional impact (\[[@CR7]\];\[[@CR37]\];\[[@CR55]\];\[[@CR139]\];\[[@CR152]\];\[[@CR159]\]).

Whole-grains are hypothesised to contribute positively to human health due to their fibre, minerals (Table[1](#Tab1){ref-type="table"}), vitamins (e.g., vitamins B, D and E), phenolic compounds, phytoestrogens (lignans), and other phytochemicals (\[[@CR155]\]). These compounds may influence biological functions individually or synergistically. Whole grain rice contains similar types of compounds to other cereal grains albeit with a few unique types and in unique percentages.

Epidemiological studies suggest consuming whole-grains provides a protective effect against several chronic diseases. Whole-grain rice contains unique types and amounts of some phytochemicals such as the gamma-oryzanol and tocotrienol fractions. Numerous cell culture, animal, and human-based studies have demonstrated the potential health benefits of consuming whole-grain rice and some of its phytochemical fractions. The majority of these studies have focused on the reduction of risk factors for cardiovascular disease (\[[@CR34]\];\[[@CR63]\]), Type II diabetes (\[[@CR88]\];\[[@CR167]\];\[[@CR198]\]), and several cancers (\[[@CR188]\]). By far, the strength of the evidence lies in there being a positive relationship between whole grain rice consumption and reduced risk of disease. Some of the studies supporting these associations, however, have dealt with specific constituents in rice bran and endosperm, and have involved administration of fractions at higher intakes than would be practical from consuming whole grain rice. However, it is possible that these fractions may impact biological targets synergistically and thus exert much higher chemo-preventive efficacy than that found for individual compounds. This possibility may be even more likely when whole grain rice is consumed as part of the daily diet over a long period of time.

The bran components with potential nutritional value include the vitamin E complex of unpolished rice, which is unusually high, ranging from 179--389 mg/kg bran, with an average of 72.5% of the isomers being tocotrienols (\[[@CR13]\]). Other cereals contain much lower average amounts of Vitamin E compared with rice: wheat 23 mg/kg, barley 8 mg/kg, spelt 18.1 mg/kg, and rye 11.9 mg/kg (\[[@CR114]\]). The lipid content of rice bran is also high in comparison to other grains. Its primary unsaturated fatty acids are oleic, linoleic and alpha-linoleic, while its primary saturated fatty acids include palmitic and stearic acids. The non-saponifiable fraction of rice bran oil contains tocotrienols, tocopherols, phytosterols, gamma-oryzanol compounds, policosanols, and saponines. Each of these phytochemical fractions consists of several compounds. For example, the gamma-oryzanol fraction is composed of ferulic acid esters of triterpene alcohols. The three primary compounds are cycloartenyl ferulate, 24-methylenecycloartanyl ferulate and campesteryl ferulate (\[[@CR192]\]), and there are at least seven more compounds in that fraction (\[[@CR4]\];\[[@CR192]\]). Rice bran also contains phenolic compounds which reportedly vary a great deal in quantity and type across different cultivars (\[[@CR53]\];\[[@CR54]\]).

### Cardiovascular disease and whole-grain rice {#Sec9}

Studies on the potential health promoting properties of rice on cardiovascular diseases began more than four decades ago (\[[@CR110]\]). These studies report positive effects of whole-grain rice (and several of its fractions) consumption on cardiovascular disease risk factors, such as hypertension and cholesterol, using rodents, rabbits, non-human primates, and humans (\[[@CR34]\]). The association between whole-grain consumption and protection against heart disease and stroke is considered unequivocal by many, but the exact mechanism is not clear (\[[@CR47]\]).

### Hypertension {#Sec10}

Hypertension is a significant risk factor for coronary disease. The Dietary Approaches to Stop Hypertension (DASH) diet recommends those with hypertension to increase consumption of whole-grains (\[[@CR97]\]). These recommendations are based on the findings of cross-sectional studies examining the correlations between lifestyle and the development of cardiovascular disease. Conclusions from studies examining the specific effect of whole grain consumption on blood pressure, however, have been inconsistent (\[[@CR36]\];\[[@CR129]\]). Many of these studies did not control dietary composition except for whole-grain content and some used whole-grain fractions as opposed to whole-grain foods. By including whole-grain rice as a focus, the design of many of the previous studies evaluating whole-grain consumption and hypertension improved (\[[@CR63]\]). Non-hypertensive men with elevated plasma cholesterol levels were fed an American Heart Association Step 1 diet with or without inclusion of unpolished rice/whole wheat, barley, or a combination in a Latin square design. Also controlled were levels of protein, calcium, magnesium, sodium, and potassium in the diets. Systolic, diastolic, and mean arterial blood pressures were reduced in those who consumed soluble fibre from barley or insoluble fibre from unpolished rice and whole wheat, and consumption of the Step 1 diet without the whole-grain component did not have any effect on blood pressure (\[[@CR63]\]).

### Serum lipid levels {#Sec11}

A large number of animal, nonhuman primate, and human-based studies provide strong evidence that rice bran and its fractions lower serum cholesterol and triglyceride levels (\[[@CR34]\]). One study, using 18 humans with moderately-high blood cholesterol levels, were fed 100 g per day rice bran or oat bran for two 3-week periods in a crossover design (\[[@CR69]\]). Prior to each bran phase, a control diet without bran was provided. Total cholesterol levels decreased when rice bran or oat bran was consumed, though neither of the brans had a significant effect on HDL- and VLDL- cholesterol or triglycerides (\[[@CR69]\]). Another human study evaluated the effect of rice bran, oat bran and a rice starch placebo on moderately hypercholesterolemic, non-smoking, non-obese adults during a 6-week, randomised, double-blind trial (\[[@CR51]\]). The 23 males and 21 females were given 84 g of product per day to consume in addition to their regular diet. Significant total cholesterol reduction and improvement in the total cholesterol to HDL-cholesterol ratio in most of these individuals who consumed the bran was reported. Again, there was no significant difference between the effectiveness of the rice and oat bran (\[[@CR51]\]). Both these studies offer rice consumers an option that does not include changing their preferred staple.

Studies using hamsters and nonhuman primates have concluded that the rice bran oil fraction gives rice bran its cholesterol lowering properties (\[[@CR85]\];\[[@CR113]\]). Studies using moderately-hypercholesteroleimic healthy humans (n = 26) in a parallel arm design and a randomised crossover design, have compared the effects of a diet including dietary fibre from rice bran or defatted rice bran, and dietary lipids from rice bran oil or another oil blend with a fatty acid composition similar to rice (\[[@CR107]\]). The study showed that defatted rice bran did not lower lipid levels, and consumption of the diet containing rice bran oil compared to the control diet resulted in lower total cholesterol levels (\[[@CR107]\]), suggesting that the oil in rice bran contains unique compound/s for lowering cholesterol. The fractions of primary focus for this capacity have been the tocotrienols, sterols, gamma-oryzanol and policosanols.

Less than 1% of all research published regarding the Vitamin E complex has focused on tocotrienols. Reviews indicate that most of the research on tocotrienols has focused on this fraction from palm oil or individual isomers, while only a limited focus has been placed on this fraction in rice bran (\[[@CR121]\];\[[@CR137]\];\[[@CR148]\]). Research with cell cultures has shown that tocotrienols together and as individual isomers influence cholesterol synthesis by regulating the expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, the rate-limiting enzyme in the cholesterol synthesis pathway (\[[@CR126]\]). Interestingly, α-tocopherol has shown an opposite effect in hypercholesterolemic human subjects (\[[@CR134]\]).

Conflicting conclusions have been reported from clinical trials that examined the effects of rice and palm tocotrienol rich fractions on cholesterol (\[[@CR121]\];\[[@CR137]\];\[[@CR148]\]). The studies that reported an inhibitory effect of tocotrienols on total cholesterol levels used preparations with less than 20% tocopherols. The reverse was reported for studies that used preparations with a greater percentage of tocopherols. Rice bran reportedly contains approximately 25% tocopherols and 75% tocotrienols (\[[@CR13]\]), so this could be one of the ways that rice bran lowers cholesterol. Potentially confounding aspects of the design of human trials have been that the relative amounts of the four tocotrienol isomers varied between these studies. Several of these studies, also, did not control the amount of dietary lipids and alcohol consumed by the subjects; both have been reported to modulate the effects of tocotrienols (\[[@CR133]\]).

Policosanols are a mixture of primary long-chained alcohols. Sugarcane policosanols reduced plasma LDL cholesterol in several clinical trials of varying duration and at efficacious doses, ranging from 2 to 40 mg per day (\[[@CR30]\];\[[@CR174]\]). Whole-grain rice contains policosanols but its individual compounds are found in different ratios compared to the similar fraction in sugarcane. Rice policosanols (10 mg per day), when fed to hypercholesterolemic men and women in a randomised, double-blind, crossover, placebo-controlled trial (n = 70), reportedly lowered the subjects plasma total cholesterol, and increased levels of Apolipoprotein A-1, the major protein componenet of HDL (\[[@CR138]\]). However, a lack of cholesterol-lowering efficacy of sugarcane policosanols was reported from a study with a similar design to those reported above (\[[@CR14]\]). Thus, the association between policosanol consumption and plasma cholesterol reduction is unclear. To clarify this situation, future research will need to take into consideration that the specific compounds and amounts of each type in the policosanol fraction vary both between and within crops.

Numerous studies with rodents have reported that the gamma-oryzanol fraction from rice bran is able to lower serum cholesterol levels in animals fed different model hypercholesterolemic diets (\[[@CR34]\]). The mechanism of action appears to include increased faecal excretion of cholesterol and its metabolites (\[[@CR190]\]). These authors also reported that ferulic acid from rice bran showed anti-atherogenic properties, but through a different mechanism. The serum cholesterol lowering properties of gamma-oryzanol have not been confirmed in humans.

While it seems clear that there is an association between the consumption of whole grain rice and a lowering of cardiovascular risk factors, the mechanisms leading to this could be due to multiple compounds. In order for rice improvement programs to make use of these associations, there is a need for investment targeted specifically towards identifying the mechanism of risk reduction, understanding variability within rice for managing cardiovascular risk factors, and then using that information to develop phenotyping tools so that selection for heart-healthy varieties of rice is possible in the future.

### Cancers and whole grain rice {#Sec12}

A meta-analysis of prospective epidemiologic studies suggests that consumption of whole-grain products is inversely associated with the development of several forms of cancer (\[[@CR188]\]). However, only a limited number of human, animal and cell culture-based studies that specifically evaluate the association of whole grain rice, or it's fractions, with cancer risks have been done, and many studies cannot be done in humans due to limitations in analytical capability. The studies indicate that whole grain rice contributes to mitigating cancers, tumour growth and proliferation by two different mechanisms. There is an increasing body of evidence that resistant starch (RS) in the whole grain provides one mechanism, and the second is through bioactive compounds that could be present in the bran layer of the rice. However, neither mechanism is well understood, but the results described below suggest that both mechanisms are worthy of pursuing further.

Colon cancers arise from benign neoplasms and evolve into adeno-carcinomas through an histological sequence beginning with either adenomas or hyperplastic polyps. A link between dietary fibre and reduced risk of colon cancer was first proposed several decades ago. That association remains controversial; however, confidence in a link between whole grain consumption and reduced risk of colorectal cancers is growing (\[[@CR8]\];\[[@CR17]\];\[[@CR125]\];\[[@CR146]\];\[[@CR169]\];\[[@CR167]\];\[[@CR168]\]). Several mechanisms have been proposed to explain this possible association. Cereal bran may have a protective effect against colorectal cancer by altering the colonic bacteria profile via addition of fermentable carbohydrates, such as resistant starch (RS).

Recent evidence suggests that RS results in an increased production of short chain fatty acids (SCFA) such as butyrate in the colon (\[[@CR167]\]). These are considered to play a number of roles in bowel health, including recovery from chronic diarrhoea, lowering absorption of potential carcinogens, and repair of damaged DNA (\[[@CR167]\]). Studies using pigs found faecal SCFA levels higher when the pigs were fed whole grain rice relative to feeding with milled rice and bran. This was reportedly due to greater RS in the whole grain rice wherein the bran layer protected the starch from digestion, enabling the starch to ferment in the large intestine where it produced SCFA (\[[@CR17]\]). Consistent with this, a systematic study of RS in a diverse set of rices showed that RS in unpolished cooked rice was 30% higher than in the polished cooked rice of the same variety (\[[@CR189]\]), probably due to the bran layer preventing digestive enzymes from accessing the starch. RS can also be manipulated in polished grain. The starch branching enzyme IIb gene (*SBEIIb*) has a large effect on RS, and varieties that carry a mutation in this gene show elevated RS (\[[@CR26]\]), but when expression of that gene is completely silenced with specific transgenic techniques, the RS is significantly increased (\[[@CR26]\]).

Familial adenomatous polyposis is an hereditary condition that predisposes people to colon cancer. Apc(Min) mice carry a mutation in the same gene that causes familial adenomatous polyposis in humans. These mice develop large numbers of intestinal tumors at an early age and are thus used as a model for evaluating chemo-preventive interventions for humans with intestinal polyps. When rice bran was included in the diet in a cross-over experiment, the Apc(Min) mice showed a decrease of 51% in the number of intestinal adenomas (\[[@CR177]\]). The mechanism is unclear, but is likely to be due to compounds present in the bran.

Isoprenoids are known to possess potent anti-cancer activity (\[[@CR148]\]), and whole grain rice contains several different types of these compounds. For example, γ-tocotrienol, the tocotrienol that rice has in the largest quantity, has been documented using tissue culture techniques to be the most potent anti-cancer Vitamin E isoform of all the isomers that occur in nature (\[[@CR148]\]). Numerous studies documenting this observation have shown that tocotrienols and γ-tocotrienol in particular, target Nuclear Factor-κB (a transcription factor) which reduces inflammation and thus mediates the impact of carcinogens (\[[@CR1]\];\[[@CR112]\]). Work using mice not only supports the results found using cell lines, but when extrapolated to humans, indicates that an efficacious dose of tocotrienols could be consumed from the diet (\[[@CR68]\]). Other isoprenoids in whole grain rice have been reported to interfere with the colony-forming ability of breast and colon cancer cells (\[[@CR76]\]). Eight phenolic compounds, protocatechuic acid (\[[@CR76]\]), ρ-coumaric acid (\[[@CR201]\]), caffeic acid (\[[@CR76]\]), ferulic acid (\[[@CR166]\]), sinapic acid (\[[@CR76]\]), vanillic acid (\[[@CR201]\]), methoxycinnamic acid and tricin (\[[@CR76]\]), were identified in the extracts studied. Of these compounds, the flavonoid tricin has received the greatest research attention (\[[@CR200]\]) which has likely been due to its greater activity in interfering with cancer cells in tissue culture experiments at levels lower than the other phenolics studied, making it an easier compound to study than others.

During tumour metastasis, a critical early step is cell invasion of the basement membrane - a dense meshwork of collagen, glycoproteins, and proteoglycans which, under normal circumstances, prevents cells from moving away from their sites of origin. Cancer cells, however, secrete several different types of enzymes that digest the proteins in the basement membrane (\[[@CR41]\]). When the membrane has been sufficiently weakened, the tumour is able to push through the membrane (\[[@CR95]\]), which allows cells to invade surrounding tissue. Another isoprenoid fraction from whole grain rice, specifically the anthocyanins cyanidin 3-glucoside and peonidin 3-glucoside were isolated and shown to inhibit the mobility and invasion ability of human hepatocellular carcinoma (SKHep-1) cells (\[[@CR31]\]). This effect was associated with a reduced expression of several proteinases. In addition, these compounds were fed to mice after subcutaneous inoculation with SKHep-1 cells. Small solid tumours were observed following cell inoculation and a 1.9-fold reduction in tumour volume and a 1.7-fold reduction in tumour weight were reported after feeding the mice the anthocyanin fraction from whole grain rice (\[[@CR31]\]). The anthocyanin, antioxidant and phenolic content ranges enormously in rice, and several studies associate it positively with coloured pericarps (\[[@CR54]\];\[[@CR65]\];\[[@CR119]\];\[[@CR152]\]). Figure[3](#Fig3){ref-type="fig"} shows the diversity in the colour of the rice pericarps. Figure 3**Diversity in the colour of the bran of unpolished rice.**

The studies described above all indicate that whole grain rice plays a significant role in preventing cardiovascular risk factors, tumour growth and tumour proliferation, through both the mechanical protection of starch by the bran with the subsequent benefits of SCFA, and the range of bioactive compounds in bran. These data call for stronger links between rice researchers and the medical fraternity, significant investment in research to detect and identify the important grain constituents and to quantify the nutritional impact in humans, and techniques to deliver to rice improvement programs to enable selection on bran quality. The bran content of rice ranges from 5--8% (\[[@CR12]\]), which could be an immediately selectable trait for rice varieties targeted to markets that consume either whole-grain rice, or different forms of it, such as pre-germinated rice, which is also consumed as whole-grain rice.

### Type II diabetes mellitus and rice {#Sec13}

Diabetes is a chronic evolving disease associated with a variety of micro- and macro-vascular complications. Although pharmacological therapies are effective, the diabetes prevention trials in Finland and the U.S. remind us that nutrition and lifestyle approaches can be more effective in delaying onset of the disease. In fact, these nutrition and lifestyle approaches to diabetes prevention and treatment should be given at least as much attention as drug therapies. The use of low glycaemic index (GI) foods should be considered as one of a number of tools available to manage, or prevent the onset of, Type II diabetes.

The GI of a food quantifies the rate of release of glucose into the blood in response to the carbohydrates consumed. The glycaemic load (GL) is the mathematical product of the GI and the amount of carbohydrate in the food. A recent meta-analysis of 37 prospective observational studies concluded that GI and GL are both strongly associated with Type II diabetes and its chronic diseases (\[[@CR11]\]). Another recent study confirms this (\[[@CR64]\]), and a prospective cohort study and systematic review of six other cohort studies concluded that two-servings-per-day of a whole grain was associated with a 21% decrease in risk of type II diabetes (\[[@CR108]\]). These studies consisted of 286,125 participants and 10,944 of these had Type II diabetes. A feeding trial of patients with Type II diabetes found that those on the diet of lower GI had a significant improvement in blood sugar status compared with those on the higher GI diet (\[[@CR115]\]), strongly suggesting that choice of carbohydrate will aid in the management of blood sugar status.

Rice has generally been considered to be a food of high GI (\[[@CR24]\]). Several studies link the consumption of rice with increased risk of developing Type II diabetes (\[[@CR111]\];\[[@CR178]\]). Those studies were carried out in Japan and Shanghai respectively, and in both those places, the rices consumed are likely to be of high GI because they are low amylose varieties (\[[@CR142]\];\[[@CR46]\]). Both\[[@CR111]\] (2010) and\[[@CR178]\] (2007) report an association between diabetes and rice consumption, and the association was stronger in people with low physical activity coupled with high intake of rice. Another study based in Australia shows that the risk of developing Type II diabetes was highest in people who consume high levels of white bread together with low physical activity (\[[@CR73]\]). The GI of white bread is high (\[[@CR48]\]). Together, the three studies indicate that consumption of carbohydrate of high GI is likely to increase risk of Type II diabetes, especially when coupled with low physical activity, irrespective of the grain delivering the carbohydrate. In areas where rice is the staple, correlations between consumption of high GI rice and Type II diabetes will be found, however where wheat is the staple, the correlations with Type II diabetes will be found for those who consume white bread. Furthermore, when the diversity of rice and rice products is explored, a significant range in GI has been demonstrated. For a set of 260 varieties of polished rice, GI ranged from 52 -- 92 (\[[@CR46]\]). Rice products, such as parboiled rice and rice vermicelli, have also been shown to give a GI of at least 10 units below the GI of the white rice of the same variety (\[[@CR136]\];\[[@CR144]\]). These studies suggest that particular varieties of rice and rice products can be chosen to manage Type II diabetes, or possibly prevent the onset of the condition.

It is currently unclear whether whole-grain rice (unpolished) offers any advantage over polished rice for the management of blood glucose. A prospective study in the US reported that consumption of polished rice led to a greater likelihood of developing Type II diabetes than consumption of whole-grain rice (\[[@CR160]\]). However,\[[@CR160]\]) compared the average GI of brown and white rice published by\[[@CR48]\]), but only three varieties were tested as both brown and white rice. Comparing the GI values of the brown and white rice of the three varieties, Doongara, Amaroo and Pelde, showed no difference in GI for the brown and white forms of Doongara and Amaroo (\[[@CR48]\]). Furthermore, other differences between the levels of physical activity and other dietary choices of the brown and white rice consumers studied by\[[@CR160]\]) could easily contribute to the difference in the incidence of Type II diabetes. Two earlier studies that compared the GI of different varieties of whole-grain (brown) rice with the polished rice of the same variety gave conflicting results. The first study measured GI in eight healthy volunteers who consumed whole-grain and polished rice in a randomised experiment, and no difference in blood glucose response was found between the pairs of whole-grain and polished for the three varieties (\[[@CR24]\]). The second study found significantly lower blood glucose responses when participants consumed the whole-grain rice compared to the polished rice of the same variety (\[[@CR123]\]). These differences could be due to varietal differences, differences in cooking, differences in measuring GI, or other factors of diet and lifestyle. It is therefore not yet possible to conclude if the consumption of whole-grain rice gives any advantage over polished rice for the management of blood glucose status.

The Nurses\' Health Study and the Harvard School of Public Health indicate that higher intakes of Mg may reduce the risk of developing Type II diabetes (\[[@CR99]\]). Research has shown that low levels of Mg may impair insulin sensitivity or function. Consuming adequate levels of Mg may help insulin function properly in the body, which may assist in preventing Type II diabetes. Table[1](#Tab1){ref-type="table"} shows a significant amount of Mg is found in the whole-grain, but polishing to white rice removes 86% of it (\[[@CR66]\]).

The diversity of compounds found in the bran, metabolites and minerals in the grain, structures of starch, non-starch polysaccharides, and different cooking and processing methods are all likely to have some impact on the digestibility of rice. Given that rice consuming countries face a grand challenge with skyrocketing rates of Type II diabetes, it is essential that we understand a lot more about the digestibility of rice and the importance and roles of other bioactive compounds from rice and bran. Investment is needed to enable science to identify and validate important compounds, and deliver this knowledge, as phenotyping tools, to rice improvement programs.

### Consumption of whole grain rice {#Sec14}

Unpolished rice is not widely consumed world-wide, and is most likely to be consumed in Western countries by health-conscious consumers. It can be found in the markets in most Asian countries, but the belief is that the unpolished rice is for the elderly, and anecdotally it is said to provide nutritional and metabolic benefits. However, there are two methods of processing rice that are likely to provide some of the nutritional value of whole-grain to consumers. The first is parboiling of the paddy before it is polished to white rice. The second is the relatively new technique of pregerminating the brown rice grain prior to cooking the brown rice, which alters the biochemical profile of the bran and improves the cooking and sensory properties of brown rice.

Parboiling involves three basic processes prior to dehulling and polishing: soaking (or steeping), steaming/boiling, and drying (\[[@CR33]\]). Parboiling is practiced in India, Pakistan, Sri Lanka, Bangladesh, West Africa, the Americas and Europe, and the methods used are all slightly different. After parboiling, the rice is polished before it is consumed, and the polished parboiled rice is considered to be of superior nutritional value compared to polished rice that has not been parboiled (\[[@CR5]\];\[[@CR127]\]). The nutritional advantage of parboiled polished rice is thought to be due to the leaching of minerals and water-soluble vitamins from the bran layers into the endosperm during the parboiling process (\[[@CR5]\];\[[@CR84]\];\[[@CR117]\]). However, not all migrating minerals are recovered in the endosperm. Comparisons between the mineral content of brown (not parboiled) and parboiled brown rice of the same variety show slight variations for the concentration of Fe, Zn and Ca, suggesting that a proportion of these minerals was lost during the parboiling process (\[[@CR70]\]). Two studies have also shown a slight decrease in carotenoid content of parboiled rice (0.003 mg to 0.001 mg/100 g) (\[[@CR50]\];\[[@CR120]\]), again, presumably due to leaching. Parboiling leads to the migration of thiamine, riboflavin and bran pigments, such as bioactive anthocyanins, into the grain (\[[@CR91]\];\[[@CR102]\]). However, there is no systematic study quantifying (i) leaching from the bran into the endosperm, or (ii) the nutritional value of polished parboiled rice due to different parboiling treatments, and no information can be found about the leaching patterns of the classes of bioactive compounds discussed above.

Pregermination is another processing method that could enable consumers to avail of the nutritional value of bran. In this process, the brown rice is soaked at 37°C for 24 h to initiate the germination process (\[[@CR43]\];\[[@CR141]\]). The rice is then dried, and vacuum-sealed, and it is not polished prior to consumption. Pregermination leads to extensive biochemical changes in the pregerminated rice compared with the ungerminated whole-grain (\[[@CR86]\];\[[@CR141]\]). These changes lead to significant increases in bioactive compounds such as γ-aminobutyric acid (GABA), dietary fibre, inositols, ferulic acid, phytic acid, tocotrienols, Mg, K, Zn, γ-oryzanol, and prolylendopeptidase inhibitor (\[[@CR86]\]). Total phenolics increased to a maximum level after a germination time of 24 hours while GABA, which was not present before germination, developed in significant quantities upon pre-germination (\[[@CR72]\]). Novel acylated steryl glucosides appeared at the same level of bioactivity as found in soybean after pre-germination (\[[@CR173]\]). In countries of South-East and North Asia, pregerminated rice is marketed with the nutritional label of GABA rice (\[[@CR122]\]).

Germination provides further nutritional value by reducing anti-nutritional factors in whole-grain rice, such as phytate (\[[@CR94]\];\[[@CR149]\]). Phytate inhibits the bioavailability of minerals by forming stable, indigestible complexes (\[[@CR101]\];\[[@CR182]\]). The process of germination activates the production of phytase, which catalyses the hydrolysis of phytate (\[[@CR162]\]). Moreover, the sensory properties of pregerminated rice are considered to be superior to those of brown rice (\[[@CR49]\]), and this, together with the nutritional enhancement, could increase the acceptability of pregerminated rice amongst consumers of polished rice.

Exploring genetic variability for the response to pregermination could lead to a wealth of new information about the nutritional potential of rice. Partnerships with the medical profession could enable nutritional impact to be quantified, which could then flow through to rice improvement programs, to improve the nutritional value of rice by maximising the potential of the raw material, and of the process.

New technologies for selecting tools for nutritional quality {#Sec15}
------------------------------------------------------------

With the importance and relevance of nutritional components being clear, there is an increasing demand for more detailed information on the molecular mechanisms behind the biochemical content of the rice grain, both before harvest and after polishing. New high throughput phenotyping platforms such as metabolomics, giving unprecedented insights into grain composition, and HTP genotyping platforms such as Next Generation Sequencing, RNAseq and SNP arrays, which reveal the genetics behind varietal differences, have huge potential.

Metabolomics as a new phenotyping tool for nutritional compounds {#Sec16}
----------------------------------------------------------------

Metabolomics approaches for plants have now been around for little more than 10 years (\[[@CR42]\]), and give us the capacity to study the biochemical composition of plant materials in an untargeted manner (\[[@CR60]\];\[[@CR61]\]). The biochemical profiles obtained, using a range of now standard platforms, cover most of the main groups of nutritionally-relevant small molecules. Large (polymer) molecules are not included, which makes metabolomics an excellent complement to other approaches targeting key nutrient groups, such as starch and proteins (\[[@CR39]\];\[[@CR60]\]). Our knowledge of the plant metabolome is still limited, as was demonstrated recently using rice as an example to show, that even after a detailed (literature) analysis of all available information on this crop's metabolites, we must still only have visualised just a small fraction (\[[@CR87]\]). Metabolomics is helping to increase this coverage, but much work is still needed if we are to link e.g. key nutrient traits with mixtures of known metabolites (\[[@CR40]\];\[[@CR158]\]).

For rice, only a few true metabolomics studies have been published to date (see (\[[@CR62]\];\[[@CR118]\];\[[@CR165]\])). Nevertheless, the potential of the technology has clearly been recognised, particularly in areas such as stress tolerance (\[[@CR3]\];\[[@CR165]\]), grain development, grain quality, and nutritional value (\[[@CR45]\];\[[@CR193]\]). While early rice metabolomics was often performed on leaf material (Capillary Electrophoresis MS, (\[[@CR143]\];\[[@CR142]\]), later, additional approaches have been used to analyse rice grains (GC-MS on transgenic rice, (\[[@CR202]\]); 1D and 2D GC-MS on brown rice, (\[[@CR90]\]); HSSE/GC-MS on rice grains, (\[[@CR57]\])). Only one metabolomics study has so far been published on rice bran, but specifically in the context of its use as a suitable starting material for fermentation to produce health-promoting phytochemicals (\[[@CR140]\]). Methods for the untargeted analysis of rice grain volatile compounds, which are important in determining key phenotypic traits in fragrant rices such as Basmati and Jasmine types, have also recently been published (\[[@CR19]\];\[[@CR27]\];\[[@CR176]\]). GC-MS results have revealed that rice fragrance (measured from extracts or directly from head space) is created from a rich mix of a wide range of chemically-diverse compounds (\[[@CR25]\];\[[@CR27]\];\[[@CR28]\]). Many of these can be associated with positive fragrance traits, but others can be linked to off-flavour/negative traits. Advanced knowledge of both is essential when we wish to design breeding programmes with increased capability to select for nutritional quality. Using LC-MS, (\[[@CR71]\]) also revealed a vast richness in the non-volatile metabolites, many of which could be associated with nutritional value or potential health benefits.

In the most extensive integrated approach to date,\[[@CR27]\]) have used five complementary metabolomics platforms (NMR, LC-MS, GC-MS, GC-TOF-MS and ICP-MS) to gain a broad insight into minerals and metabolites in polished rice grains. Three contrasting genotypes were used in a proof of concept experiment, and it was demonstrated that all platforms could readily distinguish each genotype. This indicates that irrespective of analytical platform or group of metabolites studied, chemical diversity is sufficient to enable genotype-specific profiles to be identified. This individuality in diversity is presumably also the fundamental basis of the high discriminatory potential of the human palette to distinguish rice varieties after cooking, even when the grains come from genetically closely related varieties (\[[@CR27]\];\[[@CR29]\]). Of course, metabolic complexity is, to a large extent, the reflection of complexity resulting from genetic polymorphism. Our growing potential to exploit the sequence of the rice genome, in combination with e.g. full genome transcriptomics, comprehensive SNP genotyping and genome-wide association studies using multi-platform metabolomics studies (\[[@CR27]\]), is predicted to enable us to make unprecedented steps in our quest to understand better the molecular basis of rice metabolite profiles, and design tailor-made nutrition-directed breeding strategies for specific rice varieties, whole-grain and polished, to meet future nutritional needs.

New genotyping tools for defining the genetics of nutritional quality {#Sec17}
---------------------------------------------------------------------

Over the last ten years, genotyping tools have advanced immeasurably. Genome-wide genotyping has become almost routine, and now the current advances are increasing the resolution and application of the technology to rice exponentially (\[[@CR104]\]). Now, single nucleotide polymorphisms (SNPs) are replacing most genotyping techniques, and with new SNP techniques, DNA from a single variety can be screened at many loci in a single pass (\[[@CR20]\];\[[@CR105]\]).

Routine genotyping at 384 SNP loci is currently possible for rice, for both *indica* and *japonica* subspecies (\[[@CR20]\];\[[@CR191]\]). However, just as genotyping at 384 loci has become routine, the number of loci on newly developed chips has risen to 44000, and is soon to reach 1, 000,000 loci (\[[@CR171]\]). As this rich collection of SNPs are discovered, the genotyping can be used to develop mapping populations rapidly (\[[@CR20]\]), or used to associate with phenotype data (\[[@CR27]\]), or a particular set of SNPs can be selected and used for specific genotyping in a breeding program (\[[@CR32]\]).

Once phenotyping tools can identify compounds and structures that offer nutritional benefit, the new genotyping tools offer the opportunity for rapid discovery of the genes responsible for the phenotype. Such genetic knowledge can then be delivered to breeding programs to enable genetic selection for compounds, structures and traits that offer nutritional benefit.

Consumer acceptance of nutritionally enhanced rice {#Sec18}
--------------------------------------------------

Consumers have eaten particular varieties for many generations in the belief that they give nutritional value. For example, rice in India with red bran is marketed and prescribed by Ayurvedic practioners for its health benefits such as controlling hypertension and diabetes (\[[@CR2]\]). In Laos, specific varieties are consumed by post-partum women (\[[@CR22]\]). Belief in these effects on health has been upheld for many generations, but the mechanisms through which they act are not clear. Any rice that is sold unpolished in the U.S. can legally be marketed with the following FDA-approved health claim: "Diets rich in whole-grain foods and other plant foods and low in total fat, saturated fat, and cholesterol may reduce the risk of heart disease and some cancers" (\[[@CR38]\]). However, labels are not specific, mechanisms are not well understood, impact on health is not quantified, and consumption of whole-grain rice is very low in developing countries. The purpose of the present review is to create awareness of the nutritional potential of rice; identify current progress with developing varieties for specific issues of malnutrition and chronic disease, through the understanding the constituents of the rice grain, and bringing new science to bear; and identifying new opportunities to tap into the diversity of rice and identify or develop additional nutritionally enhanced varieties. However, there are a number of issues to consider when marketing such varieties to policy makers, farmers and most importantly, consumers.

Some countries have very strict food labeling regulations, such as in Japan, while others have relatively lax laws, as in China (\[[@CR67]\]). In regions of the world with strict regulations, marketing rice as possessing a certain level of a nutrient will require that the levels are documented through laboratory testing. Labeling rice with a health claim will be particularly challenging since countries have diverse requirements for making such claims, and consumers believe claims to varying degrees (\[[@CR154]\]). Furthermore, in most regions of the world, cultivars with an enhanced nutrition profiles, such as those with elevated Zn, will need to be segregated from those without the trait so the impact is not diluted. Segregation of particular cultivars is known as identity preservation (IP) across the crop world. IP requires cultivars to be harvested, stored, and marketed separately (\[[@CR161]\]). These systems specify that particular standards be upheld, records kept, and testing be performed. In other situations IP is used to enable consumers to choose products without a particular trait, as in the case of genetically modified (GM) crops. The European Union, Japan, Australia and other regions of the world have laws requiring the labeling of GM foods (\[[@CR77]\]). Thus, IP will likely be required for a nutritionally enhanced rice to be sold whether it is created using traditional plant breeding techniques, mutation breeding, or genetic engineering.

Bringing a nutritionally enhanced rice to a consumer or a patient has its own set of obstacles. The first of these is that it is necessary to meet some of the nutritional challenges using the tools of transgenic technology. Golden rice was developed with genes from another species (maize) (\[[@CR58]\]), but the high Fe rice that best meets nutritional targets was developed using a transgenic technique to enable a gene found in all rice varieties, that usually expresses in the roots and shoots, to express in the grain as well (\[[@CR83]\]). These are different degrees of genetic modification, but will that influence consumer choice? The development of transgenic food products has been highly controversial, in spite of the fact that there was no other way to create grains of rice with nutritionally useful levels of iron or rice grains containing β-carotene. Generally consumer skepticism is focused around questions of unknown environmental and health consequences of growing or consuming the transgenic products (\[[@CR35]\]). The two transgenic products described here have been developed with the specific humanitarian objective of improving the health of the poorest people. However, consumers and policy makers have every right to ask questions, and should do so. As more trials are undertaken in different locations and in target populations, science will begin to provide the answers to the critical questions, which then will enable policy makers and consumers to make informed decisions.

A second obstacle to consumer acceptance concerns the capacity of science to quantify the nutritional impact of the nutritionally valuable rices, especially with regard to chronic diseases, and to communicate that effectively to the medical community. At present, studies investigating the impact of nutritionally enhanced rice in preventing chronic disease, or developing therapeutic strategies for controlling these, are lacking, and specific dietary recommendations are not focal points in the management of chronic diseases by the medical community.

Presently, the medical community primarily practices evidence-based medicine, which aims to apply the best available evidence gained from the scientific method to clinical decision-making. Quantifiable, evidence-based data based on extensive research would be invaluable for encouraging more medical practitioners to combine dietary recommendations with medicinal treatment as their primary strategy in managing patients with chronic diseases. However current limitations to this are the identification of grain constituents with health benefits, and the existence of rapid and accurate methods that enable data to be gathered to quantify medical impact. Techniques for testing nutritional claims from rice research would provide the conduit for collaboration between the medical community and rice scientists to enable rice varieties to be developed to provide solutions to chronic diseases.

Conclusions {#Sec19}
===========

Prioritising investment into identifying the biological causes underlying associations between rice consumption and decreased risk factors for chronic diseases would have significant and long-term impact on global nutritional challenges that have their greatest effect in developing countries. Technologies are advancing at rates rapid enough to make scientific progress in these areas, and doing so would lead to both nutritional and economic benefit in every rice-consuming country. The outputs from such research programs must be integrated with other efforts aiming to deliver climate-ready varieties that resist the challenges of the changing environment, and varieties that are acceptable to consumers. Rice that does not meet the needs of consumers in terms of physical and sensory properties will not be successful in the marketplace, but once research programs are resourced to understand the linkages between chemicals in rice and human health, and are able to deliver solid nutritional information to the medical community, consumers might be able to be persuaded to increase their consumption of wholegrain or pregerminated rice.
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